BackSELLAS Life Sciences Group Overview

SELLAS Life Sciences Group Total Assets

SELLAS Life Sciences Group's total assets is $150M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$145.38M
350.03% YoYΔ $113.08M vs prior year quarter

Peer trimmed avg / median

Loading

SELLAS Life Sciences Group Total Assets History

Loading

SELLAS Life Sciences Group vs. peers: Total Assets Comparison

Loading

SELLAS Life Sciences Group Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

SELLAS Life Sciences Group (SLS) FAQ

As of the most recent data (June 2026), SLS shows a total assets of $150M. That compares with $32M in the prior-year period — up 350.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SLS's total assets is now $150M (was $32M) — a 350.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether SELLAS Life Sciences Group is outperforming or lagging.

Tracking SLS's total assets over time shows whether SELLAS Life Sciences Group is scaling, shrinking, or reshaping that part of the business. The current reading is $150M That compares with $32M in the prior-year period — up 350.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has SELLAS Life Sciences Group's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $150M) with ownership activity and broader fundamentals.

SELLAS Life Sciences Group's total assets is $150M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.